Cystic fibrosis gene fix shows promise in lab, but study halted
NCT ID NCT05100823
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study aimed to see if a special molecule called an oligonucleotide blocker could repair the genetic instructions in cells from people with cystic fibrosis. Researchers collected cells from 16 patients and tested the molecule in the lab. The study was stopped early, so we don't have final results on whether this approach works in people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montpellier University Hospital
Montpellier, 34090, France
Conditions
Explore the condition pages connected to this study.